{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:58Z","timestamp":1790352538759,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,16]]},"DOI":"10.7759\/cureus.18822","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T21:26:14Z","timestamp":1634419574000},"source":"Crossref","is-referenced-by-count":19,"title":["Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature"],"prefix":"10.7759","author":[{"given":"Afia","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everardo E","family":"Castaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorain","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Veerapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy G","family":"Rockferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan Reddy","family":"Lankala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries","volume":"73","author":"Izmirly PM","year":"2021","unstructured":"Izmirly PM, Parton H, Wang L, et al.. Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021, 73:991-996. 10.1002\/art.41632","journal-title":"Arthritis Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees F","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017, 56:1945-1961. 10.1093\/rheumatology\/kex260","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2","article-title":"Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992","volume":"42","author":"Uramoto KM","year":"2017","unstructured":"Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis and rheumatism. 2017, 42:46-50. 10.1002\/1529-0131(199901)42:1&lt;46::AID-ANR6&gt;3.0.CO;2-2","journal-title":"Arthritis and rheumatism"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2227-1","article-title":"Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review","volume":"32","author":"Vilaiyuk S","year":"2013","unstructured":"Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol. 2013, 32:899-904. 10.1007\/s10067-013-2227-1","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky S","year":"2006","unstructured":"Bernatsky S, Boivin JF, Joseph L, et al.. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2550-2557. 10.1002\/art.21955","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative","volume":"68","author":"Ravelli A","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al.. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol. 2016, 68:566-56. 10.1002\/art.39332","journal-title":"Arthritis Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-2620. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-1412. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-2686. 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"ref10","unstructured":"1997 update of 1982 revised.pdf. (1997). Accessed. September 6, 2021: https:\/\/www.rheumatology.org\/Portals\/0\/Files\/1997%20Update%20of%201982%20Revised.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121233","article-title":"Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome","volume":"40","author":"Strippoli R","year":"2013","unstructured":"Strippoli R, Caiello I, De Benedetti F. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome. J Rheumatol. 2013, 40:761-767. 10.3899\/jrheum.121233","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan L","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020, 16:19-30. 10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318759428","article-title":"Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus","volume":"27","author":"Cohen EM","year":"2018","unstructured":"Cohen EM, D'Silva K, Kreps D, Son MB, Costenbader KH. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus. Lupus. 2018, 27:1065-1071. 10.1177\/0961203318759428","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab502","article-title":"Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study","author":"Huang LW","year":"2021","unstructured":"Huang LW, Wei JC, Chen DY, Chen YJ, Tang KT, Ko TM, Chen HH. Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study. Rheumatology (Oxford). 2021, 10.1093\/rheumatology\/keab502","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.02.002","article-title":"In-hospital mortality in febrile lupus patients based on 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome","volume":"47","author":"Ahn SS","year":"2017","unstructured":"Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ. In-hospital mortality in febrile lupus patients based on 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome. Semin Arthritis Rheum. 2017, 47:216-221. 10.1016\/j.semarthrit.2017.02.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1023","article-title":"Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center","volume":"70","author":"Dall'Ara F","year":"2018","unstructured":"Dall'Ara F, Cavazzana I, Frassi M, et al.. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Reumatismo. 2018, 70:100-105. 10.4081\/reumatismo.2018.1023","journal-title":"Reumatismo"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314559086","article-title":"Predictors of the response to treatment in acute lupus hemophagocytic syndrome","volume":"24","author":"Takahashi H","year":"2015","unstructured":"Takahashi H, Tsuboi H, Kurata I, et al.. Predictors of the response to treatment in acute lupus hemophagocytic syndrome. Lupus. 2015, 24:659-668. 10.1177\/0961203314559086","journal-title":"Lupus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya S","year":"2008","unstructured":"Fukaya S, Yasuda S, Hashimoto T, et al.. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008, 47:1686-1691. 10.1093\/rheumatology\/ken342","journal-title":"Rheumatology (Oxford)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000224708.62510.d1","article-title":"Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome","volume":"85","author":"Lambotte O","year":"2006","unstructured":"Lambotte O, Khellaf M, Harmouche H, et al.. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore). 2006, 85:169-182. 10.1097\/01.md.0000224708.62510.d1","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand PE","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, et al.. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017, 16:743-749. 10.1016\/j.autrev.2017.05.010","journal-title":"Autoimmun Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12305","article-title":"Systematic review: macrophage activation syndrome in inflammatory bowel disease","volume":"37","author":"Fries W","year":"2013","unstructured":"Fries W, Cottone M, Cascio A. Systematic review: macrophage activation syndrome in inflammatory bowel disease. Aliment Pharmacol Ther. 2013, 37:1033-1045. 10.1111\/apt.12305","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16(10)","author":"Atteritano M","year":"2012","unstructured":"Atteritano M, David A, Bagnato G, et al.. Haemophagocytic syndrome in rheumatic patients. A systematic review. European review for medical and pharmacological sciences. 2012, 16(10):1414-1424.","journal-title":"European review for medical and pharmacological sciences"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2018.06.006","article-title":"Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis","volume":"2","author":"Brito-Zer\u00f3n P","year":"2018","unstructured":"Brito-Zer\u00f3n P, Kostov B, Moral-Moral P, et al.. Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis. Mayo Clin Proc Innov Qual Outcomes. 2018, 2:267-276. 10.1016\/j.mayocpiqo.2018.06.006","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)61048-x","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome\r\n\r\n. The Lancet. 2014, 383:1503-1516. 10.1016\/s0140-6736(13)61048-x","journal-title":"The Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcx183","article-title":"Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis","volume":"111","author":"Zhou M","year":"2018","unstructured":"Zhou M, Li L, Zhang Q, et al.. Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis. QJM. 2018, 111:23-31. 10.1093\/qjmed\/hcx183","journal-title":"QJM"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9695367","article-title":"Hemophagocytic lymphohistiocytosis in pregnancy: a case series and review of the current literature","volume":"2019","author":"Parrott J","year":"2019","unstructured":"Parrott J, Shilling A, Male HJ, Holland M, Clark-Ganheart CA. Hemophagocytic lymphohistiocytosis in pregnancy: a case series and review of the current literature. Case Rep Obstet Gynecol. 2019, 2019:9695367. 10.1155\/2019\/9695367","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1654-4","article-title":"Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy","volume":"33","author":"Kim JM","year":"2013","unstructured":"Kim JM, Kwok SK, Ju JH, Park KS, Park GS, Kim HY, Park SH. Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int. 2013, 33:767-771. 10.1007\/s00296-010-1654-4","journal-title":"Rheumatol Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3879148","article-title":"Autoimmune-associated hemophagocytosis and myelofibrosis in a newly diagnosed lupus patient: case report and literature review","volume":"2019","author":"Gauiran DT","year":"2019","unstructured":"Gauiran DT, Cheng PV, Pagaduan CR, Santos MC. Autoimmune-associated hemophagocytosis and myelofibrosis in a newly diagnosed lupus patient: case report and literature review. Case Rep Hematol. 2019, 2019:3879148. 10.1155\/2019\/3879148","journal-title":"Case Rep Hematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.022","article-title":"Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment","volume":"47","author":"Ceccarelli F","year":"2017","unstructured":"Ceccarelli F, Perricone C, Cipriano E, et al.. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017, 47:53-64. 10.1016\/j.semarthrit.2017.03.022","journal-title":"Semin Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03139-4","article-title":"Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry","volume":"146","author":"Birndt S","year":"2020","unstructured":"Birndt S, Schenk T, Heinevetter B, et al.. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. J Cancer Res Clin Oncol. 2020, 146:1065-1077. 10.1007\/s00432-020-03139-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/424381","article-title":"Dynamic changes, cut-off points, sensitivity, and specificity of laboratory data to differentiate macrophage activation syndrome from active disease","volume":"2015","author":"Assari R","year":"2015","unstructured":"Assari R, Ziaee V, Mirmohammadsadeghi A, Moradinejad MH. Dynamic changes, cut-off points, sensitivity, and specificity of laboratory data to differentiate macrophage activation syndrome from active disease. Dis Markers. 2015, 2015:424381. 10.1155\/2015\/424381","journal-title":"Dis Markers"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin CI","year":"2012","unstructured":"Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, Chiang BL. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol. 2012, 31:1223-1230. 10.1007\/s10067-012-1998-0","journal-title":"Clin Rheumatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000022","article-title":"Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients","volume":"93","author":"Li J","year":"2014","unstructured":"Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, Tian X. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore). 2014, 93:100-105. 10.1097\/MD.0000000000000022","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72465-exploring-macrophage-activation-syndrome-secondary-to-systemic-lupus-erythematosus-in-adults-a-systematic-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:05Z","timestamp":1707507305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72465-exploring-macrophage-activation-syndrome-secondary-to-systemic-lupus-erythematosus-in-adults-a-systematic-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.18822","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,16]]}}}